Case report: Exploration of abrocitinib in the treatment of refractory chronic spontaneous urticaria: a case series
In clinical practice, some cases of chronic spontaneous urticaria (CSU) remain difficult to treat, with up to 40% of patients showing no response to even high (4-fold) daily doses of antihistamines. Approximately 30% of CSU patients fail to achieve com…